Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

An LOH and mutational investigation of the ST7 gene locus in human esophageal carcinoma

Abstract

Frequent loss of heterozygosity (LOH) on human chromosome 7q31 has been reported in numerous malignancies. Suppressor of tumorigenicity 7 (ST7) has been identified as a candidate tumor suppressor gene in this region. To identify whether 7q31 and genetic alterations of ST7 were involved in human esophageal carcinogenesis, we performed LOH mapping of a 5.4 cM region at 7q31-q35 in 43 primary esophageal carcinomas, as well as mutational analyses of the ST7 gene in tumors with LOH in this region. Of 43 tumors, 12 (28%) showed LOH at 7q31–q35. These included four (22%) of 18 squamous cell carcinomas and eight (32%) of 25 adenocarcinomas. The peak LOH locus was D7S480, lying 4.2 Mb telomeric to ST7 and showing LOH in eight of 37 informative tumors, or 22%. No mutations were found in the entire coding or flanking intronic regions of the ST7 gene among 12 tumors with 7q-LOH. In addition, quantitative RT–PCR analyses of ST7 mRNA expression levels in 11/13 normal-tumor pairs failed to show more than a 50% decrease in tumor ST7 mRNA relative to matched normal tissues. These data suggest that LOH at 7q31–q35 is involved in the origin or progression of at least a subset of esophageal carcinomas, but that ST7 is not the target gene of this somatic event.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Gunduz M, Ouchida M, Fukushima K, Ito S, Jitsumori Y, Nakashima T, Nagai N, Nishizaki and Shimizu K . (2002). Oncogene, 21, 4462–4470.

  • Hollstein MC, Metcalf RA, Welsh JA, Montesano R and Harris CC . (1990). Proc. Natl. Acad. Sci. USA, 87, 9958–9961.

  • Hughes KA, Hurlstone AF, Tobias ES, McFarlane R and Black DM . (2001). Nat. Genet., 29, 380–381.

  • Liang H, Fairman J, Claxton DF, Nowell PC, Green ED and Nagarajan L . (1998). Proc. Natl. Acad. Sci. USA, 95, 3781–3785.

  • Miller BA, Kolonel LN, Bernstein L, Young Jr JL, Swanson GM, West D, Key CR, Liff JM, Glover CS and Alexander GA, Coyle L, Hankey BF, Gloeckler-Ries LA, Kosary CL, Harras A, Percy C, Edwards BK . (1996). Racial/Ethnic Patterns of Cancer in the United States 1988–1992, Vol 96. National Cancer Institute, NIH Pub. No. 96-4104. Bethesda, MD.

    Google Scholar 

  • Mori Y, Yin J, Rashid A, Leggett BA, Young J, Simms L, Kuehl PM, Langenberg P, Meltzer SJ and Stine OC . (2001). Cancer Res., 61, 6046–6049.

  • Riegman PH, Vissers KJ, Alers JC, Geelen E, Hop WC, Tilanus HW and van Dekken H . (2001). Cancer Res., 61, 3164–3170.

  • Roth MJ, Hu N, Emmert-Buck MR, Wang QH, Dawsey SM, Li G, Guo WJ, Zhang YZ and Taylor PR . (2001). Cancer Res., 61, 4098–4104.

  • Shibagaki I, Shimada Y, Wagata T, Ikenaga M, Imamura M and Ishizaki K . (1994). Cancer Res., 54, 2996–3000.

  • Tatarelli C, Linnenbach A, Mimori K and Croce CM . (2000). Genomics, 68, 1–12.

  • Thomas NA, Choong DY, Jokubaitis VJ, Neville PJ and Campbell IG . (2001). Nat. Genet., 29, 379–380.

  • Tobias ES, Hurlstone AFL, Mackenzie E, McFarlane R and Black DM . (2001) Oncogene, 20, 2844–2853

  • van Dekken H, Vissers CJ, Tilanus HW, Tanke HJ and Rosenberg C . (1999). J. Pathol., 188, 263–266.

  • Zenklusen JC, Conti CJ and Green ED . (2001). Nat. Genet., 27, 392–398.

  • Zenklusen JC, Oshimura M, Barrett JC and Conti CJ . (1994a). Oncogene, 9, 2817–2825.

  • Zenklusen JC, Thompson JC, Klein-Szanto AJ and Conti CJ . (1995). Cancer Res., 55, 1347–1350.

  • Zenklusen JC, Thompson JC, Troncoso P, Kagan J and Conti CJ . (1994b). Cancer Res., 54, 6370–6373.

  • Zenklusen JC, Weintraub LA and Green ED . (1999). Neoplasia, 1, 16–22.

  • Zou T, Selaru FM, Xu Y, Shustova V, Yin J, Mori Y, Shibata D, Sato F, Wang S, Olaru A, Deacu E, Liu TC, Abraham JM and Meltzer SJ . (2002). Oncogene, 21, 4855–4862.

Download references

Acknowledgements

This work was supported by USPHS grants CA95323, CA85069, CA77057, DK (to SJM), and the Medical Research Office, Department of Veterans Affairs (to SJM).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen J Meltzer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, S., Mori, Y., Sato, F. et al. An LOH and mutational investigation of the ST7 gene locus in human esophageal carcinoma. Oncogene 22, 467–470 (2003). https://doi.org/10.1038/sj.onc.1206125

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206125

Keywords

This article is cited by

Search

Quick links